ArticleScience advances2024
Hierarchical and reconfigurable interfibrous interface of bioinspired Bouligand structure enabled by moderate orderliness.
Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Strengthening Constitutive Motifs in Isotropic Fibrous Hydrogel for Exceptional Damage Resistance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Shear-flow-induced assembly of 2D nanosheets for the fabrication of composite films with high tensile strength.Nature protocols · 2026Review
- Highly Aligned Bacteria Cellulose Yarn Aggregation for Energy Generation and Strain Sensing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Superstrong and supertough biomimetic nanocellulose composites with gradient bouligand architecture.Nature communications · 2026Article
- Machine learning guided resolution of mechanical trade-off in polymer composites via stress adaptive interface.Nature communications · 2026Article
- Entropy-Driven Cellulosic Elastomer Self-Assembly for Mechanical Energy Harvesting and Self-Powered Sensing.Nano-micro letters · 2026Review
- Sustainable synthesis of amino-cellulose nanofibers for biomaterial platforms.Science advances · 2025Article
- Down-Top Strategy Engineered Large-Scale Fluorographene/PBO Nanofibers Composite Papers with Excellent Wave-Transparent Performance and Thermal Conductivity.Nano-micro letters · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introducing natural Bouligand structure into synthetics is expected to develop high-performance structural materials. Interfibrous interface is critical to load transfer, and mechanical functionality of bioinspired Bouligand structure yet receives little attention. Here, we propose one kind of hierarchical and reconfigurable interfibrous interface based on moderate orderliness to mechanically reinforce bioinspired Bouligand structure. The interface imparted by moderate alignment of adaptable networked nanofibers hierarchically includes nanofiber interlocking and hydrogen-bonding (HB) network bridging, being expected to facilitate load transfer and structural stability through dynamic adjustment in terms of nanofiber sliding and HB breaking-reforming. As one demonstration, the hierarchical and reconfigurable interfibrous interface is constructed based on moderate alignment of networked bacterial cellulose nanofibers. We show that the resultant bioinspired Bouligand structural material exhibits unusual strengthening and toughening mechanisms dominated by interface-microstructure multiscale coupling. The proposed interfibrous interface enabled by moderate orderliness would provide mechanical insight into the assembly of widely existing networked nanofiber building blocks toward high-performance macroscopic bioinspired structural assemblies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.